2017
Department of Pharma.Analysis
Sl.no | Title of the Project |
1. | Method development and validation of Moxifloxacin using RP-HPLC and UV-Method A.Chaitanya Dr. M.Sumakanth M.Pharm Ph.D |
2. | Method development and validation of ATOMOXETINE by RP-HPLC and UV-method. T.Priyanka, Dr. M.Sumakanth M.Pharm Ph.D |
3. | A Simple rapid and sensitive method development for quantification of quetapine fumarate in bulk and dosage forms using RP-HPLC and UV Method .Teepoju Priyanka ,Dr. M.Sumakanth M.Pharm Ph.D |
4. | RP-HPLC and UV method development and validation for estimation of bosenton in bulk and pharmaceutical formulation K. Sai Kalyani Dr. M.Sumakanth M.Pharm Ph.D |
5. | Method development and validation of ziprasidone by using RP-HPLC and UV in bulk and dosage forms G.Sai Sindhu M.Sumakanth M.Pharm Ph.D |
Department of Pharmaceutics
2018
S.No. | Title of the Thesis |
1 | Preparation and Characterization of Letrozole loaded Ethyl Cellulose & Eudragit S100 Nanoparticles by Solvent Evaporation & Nanoprecipitation Techniques, Aisha Tabassum |
2 | Formulation and evaluation of Ropinirole Hydrochloride Buccal Tablets ,Kommu Anusha |
3 | Preparation and Characterization of Methotrexate Loaded polymeric nanoparticles by nanoprecipitation Technique and Solid lipid nanoparticles by micro emulsion technique
Ayesha Siddiqua Gazi |
4 | Preparation and Characterization of Nanoparticulate Drug delivery system for Naproxen Sodium using various Desolvating Agents, Huda Syed |
5 | Formulation and Evaluation of ORO-Dispersable tablets of Drotavarine HCL, Padullaparti Lakshmi Krithika |
6 | Development and Characterization of Fast Dissolving film of Domperidone, Pushpala Mounika |
7 | Development of Nanoparticle drug delivery system for Cassia Senna extract, Danapagari Pravallika |
8 | Formulation and Evaluation of Simvastatin loaded polymeric nanoparticles by emulsification solvent evaporation method, Etikala Priyanka |
9 | Formulation and Evaluation of alcohol resistant tablet dosage forms of Quetiapine Fumarate, Salla Ramyasri |
10 | Formulation and evaluation of solid dispersions and nano emulsions of febuxostat, M. Sanjana Reddy |
11 | Formulation and evaluation of curcumin loaded nanoparticles, M Shruti |
12 | Formulation and evaluation of solid lipid nanoparticles of etoricoxib by employing glyceryl monostearate, Balka Swetharani |
13 | Formulation and Evaluation of Gastroretentive – Mucoadhesive Tablets of Carvedilol, G Santoshini Reddy |
2017
S.No. | Title of the Thesis |
1 | Formulation and Evaluation of Naproxen Sodium Transdermal Patch Using Natural Polymers. Afrah Siddique |
2 | Formulation And Evaluation of Solid Lipid Nanoparticles of Quetiapine Fumarate. Hari Anushree |
3 | Formulation And Evaluation of Oseltamivir Phosphate Immediate Release Tablets By Using Compression Coating Technique. Arshiya Farheen |
4 | Formulation And Evaluation of Gastroretentive Bosentan Monohydrate Tablets Using RaftTechnology. Mamatha Jirra |
5 | Formulation And Evaluation of Self Micro Emusifying Drug Delivery Systems Containing Exetimibe-BCS class II Drug. Pathuri Mounika |
6 | Formulation And Evaluation of Etoricoxib Transdermal Gel Based on Vesicular Drug Delivery Approaches. V.Ravalika |
7 | Preparation And Characterization of Naproxen Loaded Niosomes by Thin Film Hydration Technique And Ether Injection Method. M.Shreya |
8 | Formulation And Evaluation of Smedds fo Febuxostat A-BCS Class II Drug. G.Swetha |
9 | Preparation And Characterization of Naproxen Loaded Bovine Serum Albumin Nanoparticles By Desolvation Techniques And Emulsion Interfacial Reaction Method. Juveria Banu |
10 | Formulation And Evaluation of Solid Lipid Nonoparticles of Duloxetine . Nayela Aafreen |
11 | Formulation And Evaluation of Metformin Hydrochloride Immediate Release Tablets By Using Low Density Excipents. Shaziya Tasneem |
2016
S.No. | Title of the Thesis |
1 | Formulation and Evaluation of Mouth Dissolving Ablets of Statins by Tase MaskingAgent Employing Solid Dispersion Technique. G.Nikitha |
2 | Formulation And Evaluation of Mefenamic Acid Transdermal Gel Based Vesicular Drug Delivery Approaches . B.Supraja |
3 | Solibility Enhancement Studies on the Poorly soluble Drug febuxostat. Soumya Reddy |
4 | Studies On Drug Release Patterns of API (Bosentan Monohyderate) by Solid Dipersion Technique . Kunche Lalitha Priyanka |
5 | Development of ODT of Atorvastatin calcium Cyclodextrin complex using Natural Disintegrating Agents. Y.Sowmya |
6 | Preparation and Evaluation of Naproxen Nanoparticles by Emulsion Intergacial Reaction Method And Desolvation Techniques. Ayesha Siddiqua |
2015
S.No. | Title of the project | ||
1 | Formulation and evaluation of ibuprofen loaded niosomal gel by thin film hydration and ether injection method,A.Krishna sailaja | ||
2 | Formulation and evaluation of COX-2 inhibitor(Etoricoxib) loaded polymeric nanoparticles for topical drug delivery,A.Krishna sailaja | ||
3 | Preparation and evaluation of naproxen sodium loaded liposomes,ethosomes and transferosomes,A.Krishna sailaja | ||
4 | Formualtion and evalution of linagliptin and metformin hydrochloride immediate release tablets, Gopi Krishna (Scientist-Formulation Research and Development)G.Umarani,MSN Labs Private Limited, Pashamylaram, Medak |
||
5 | Comparative study of sulphasalazine loaded microcapsules,microspheres & microbeads,A.Krishna sailaja | ||
6 | Preparation and evalution of mefenamic acid loaded microspheres using natural and synthetic polymers,A.Krishna sailaja | ||
7 | Formulation and invitro evaluation of bupropion Hcl extended release matrix tablets,K.Subba Rao(Senior Executive-Formulation Research and Department) Internal guide: K.V. Ratnamala | ||
8 | Study and Development of ODT tablet of candasartan celaxitil using banana powder as disintegrant,G.Umarani | ||
9 | Process Optimization parameters of Ranolazine extended release tablets,G.RameshPDL Manager, Internal Guide: K.V. Ratnamala,Aurobindo Pharma Ltd | ||
10 | Gastroretentive drug delivery system of ciprofloxacin hcl,Chetan tilwankerProductin manager Internal guide:k.v .Ratnamala,Dr .reddy labsBachupally |
||
11 | Formulation and evaluation of osmotic controlled drug delivery of nebivolol,K.Subba Rao(Senior Executive-Formulation Research and Department) Internal guide:A.Krishna Sailaj,Lara Drugs Private Limited, Nalgonda. | ||
12 | Formulation and invitro evaluation of gastroretentive drug delivery of perindopril erbumine by using Raft Approach,K.Subba Rao(Senior Executive-Formulation Research and Department)Internal guide:K.V. Ratnamala | L | |
13 | Preparation and evaluation studies of Omeprazole microspheres | ||
14 | Formulation & invitro evaluation of liquisolid compact of felodipine,K.Subba Rao(Senior Executive-Formulation Research and Department)Internal guide:G.Umarani,Lara Drugs Private Limited,Nalgonda. | ||
15 | Preparation and evaluation of naproxen sodium loaded Bovine serum albumin nanoparticles by desolvation method,A.Krishna sailaja,RBVRR Women’s College of Pharmacy |
2015
Department of Pharmaceutical Chemistry
S.No. | Title of the project | ||||
1 | Isolation ,characterization of phyto chemical constituents and pharmacological investigation of cissus vitiginea leaves.
Dr.Sudha Parimala |
2014
Department of Pharmaceutical Chemistry
S.No. | Tittle of the project |
1 | Insilico Screening of Novel substituted purine derivatives as HSP 90 Inhibitors by 3D QSAR and Docking studies .
V Priyanka Reddy, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor |
2 | Homology modeling of STAT 3 protien and virtual Screening of novel STAT 3 inhibitors by 3D QSAR and docking studies.
B Preethi, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor |
3 | Developing of new derivatives of Indenoisoquinolene as DNA topoisomerese inhibitor by using fragment based drug designing approach.
S Madhavi Latha, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof., M Sumakanth , M.Pharm,Ph.D (Internal) |
4 | Pharmacophore Modeling, 3D QSAR, ADMET and Docking studies of Benzisothiazol & Oxadiazole hybrid derivatives as Dengue Virus NS2B/NS3 Protease inhibitors.
Amreen Begum, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D(Internal) |
5 | Virtual screening of new triazolo derivatives as JAK 2 inhibitors by 3D QSAR and docking studies.
M Mounika, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor |
6 | Homology modeling of TRPV1 protein and Insilico Screening of Novel Inhibitors by 3D QSAR and docking studies.
Ch.Srividya, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor |
7 | Insilico Screening of pyridoimidazolones & substituted pyrazoles as novel inhibitors of B RAF kinase by 3D QSAR, and docking studies.
S Haritha, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor |
8 | Virtual screening of novel Rho kinase inhibitors by 3D QSAR and docking studies.
N Vamshi Priya, Prof. M Sumakanth , M.Pharm,Ph.D(External) |
9 | Insilico Screening of novel 5 LOX inhibitors by 3D QSAR and docking studies.
Maderi Ayesha, Prof. M Sumakanth, M.Pharm,Ph.DSupervisor |
10 | Molecular modelling of Indoline derivatives as transforming growth factor beta receptor 1 (TGFBR) inhibitors by 3D QSAR and docking studies.
A Mounika, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth, M.Pharm,Ph.D |
Department of Pharmaceutics
2014
S.No. | Tittle of the project |
1 | Preparation and physicochemical characterization of vincristine sulphate loaded polycaprolactone nanoparticles by various techniques.
A Tejasri, Dr. S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. G Uma Rani,M.Pharm (Internal) |
2 | Formulation and evaluation of extended release tablets of desvenlafaxine succinate.
Mucchrla Radhika, Mr.G Ramesh,PDL & TTD Manager(External)Aurobindo Pharma Ltd. Dr. B L R Madhavi, M.Pharm,Ph.D (Internal) |
3 | Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by solvent evaporation technique and salting out method.
Aenugula Saritha Reddy, Dr. A Krishna Sailaja |
4 | Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by nanoprecipitation and ionic gelation method,
Pamulaparti Swathi, Dr. A Krishna Sailaja |
5 | Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by solvent evaporation and ionotropic gelation method.
Sreelola V, Dr. A Krishna Sailaja |
6 | Development & characterization of xanthum gum and chitosan polyelectrolyte complex as drug delivery carrier.
Mamidi Vatsalya, Dr.S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. K V Ratnamala, M.Pharm |
7 | Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by nano precipitation and desolvation technique.
Chandavath Vineela, Dr.A Krishna Sailaja, |
8 | Formulation & evaluation of or dispersible tablets of candasartan using natural super disintegrants.
Shaik Yasmeen, Mrs. G Uma Rani |
9 | Formulation and evalution oof immediate release tablets of quinaprial Hcl by direct compression method. Shwetha Margaret J L, Dr.B L R Madhavi |
10 | Pallavi M, Mr.Sridhar,M.Pharm(External)Pelcoat formulations pvt.ltd, Dr. A Krishna Sailaja |
11 | Formulation and evaluation of non effervescent gastric floating tablets of ceferoxime axitel.
Y Anisha, Mrs. K V Ratnamala, |
2013
Department of Pharmaceutical Chemistry
S.No. | Tittle of Project |
1 | Synthesis , Charecterization , Docking studies and Biological evalution of 2,4,5,6 tetra substituted Pyridazin-3(2H)-ones,
Geetha Reddy K, Prof.M.Sumakanth |
2 | Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Sulfamoyl Phenyl Pyridazinones,
Srujana S, Prof.M.Sumakanth |
3 | Optimization , Charaterization & impurity profile of Telmisartian by improved synthetic rout and evaluation of Antihypertensive activity of impurity (Chloro analaog),
K P Sunitha, Prof.M.Sumakanth |
4 | Synthesis , Characterization and Docking studies of Novel series of Pyridazinone substituted Benzene Sulfonyl Ureas,
D Sai Sudha, Prof.M.Sumakanth |
5 | Synthesis , Characterization , Docking and Biological Evalution of Novel Pyrimido(4,5-C) Pyridazines,
N Swetha, Prof.M.Sumakanth |
6 | Synthesis , Characterization , and In-Sillico evalution of Phthalazine derivatives as Antihypertensive agents,
Sumala Ravuri, Prof.M.Sumakanth |
7 | Synthesis , Characterization , Docking studies , and Biological evalution of Novel series of 4 Pyrazolyl Substituted Pyridazinones,
P Spandana, Prof.M.Sumakanth |
8 | Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Mannich bases of pyridazin 3(2H) thione,
Tejaswini V, Prof.M.Sumakanth |
2013
Department of Pharmaceutics
S.No. | Tittle of Project |
1 | Design , Development and Evaluation of Prednisolone Sodium Phosphate Orodispersible Tablets.
C Bhavani Devi Dr.B.L.R. Madhavi |
2 | Formulation and Evaluation of Sustained Release Matrix Tablets of Niacin
Sudi konda Naga Sravya Mrs. Ratnamala K V |
3 | Formulation , Characterization of imquimod w/o/w multiple emulsion for Novel Adjuvant delivery system Thumma Anusha Dr. H Sampath Kumar |
4 | Development and Evaluation of Compression coated timed release tablets of Candesartan Cilexetil for Chronotherapy
K Deepika Dr.B.L.R. Madhavi |
5 | Formulation and Evaluation of Compression coated immediate release tablets of Oseltamivir Phosphate Bala Bharathi Ponnana Dr.B.L.R. Madhavi |
6 | Formulation and Evaluation of Quinapril Hydrochloride for oral sustained release
Dara Swathisri Dr.B.L.R. Madhavi |
7 | Development of Nasal drug delivery system of Atorvastatin Calcium for enhancing bioavailability Gariganti Swathi Mrs. G Uma Rani |
8 | Formulation and Evaluation of core coated colon specific tablets of Piroxicam
B Tejaswi Dr. A.K.Sailaja |
9 | A study of formulation of micro particle of Cefuroxime Axetil using Ethyl Cellulose
Domala Usha Dr.B.L.R. Madhavi |
10 | Development and Evaluation of Naringenin loaded PLGA Nano particles for enhancement of oral Bioavailability
Anusha Gunukula Mr. S. Ramakrishna |
11 | Formulation and Evaluation of micro emulsions encompasing Muramyl dipeptide adjuvant as Novel Vaccine delivery system V Poornima Dr. H.M. Sampath Kumar |
2012
Department of Pharma Chemistry
S.No. | Tittle of Project |
1 | Synthesis & Docking studies of novel series of Pyridazine(6,1-c)(1,2,4) triazine derivatives as PDE4 inhibitors, Ms. S P Anupama, Prof.M.Sumakanth
|
2 | Development of Industrial process for N-methyl pyridine-2-aldoxamine salts of Pharmaceutical importance. Ms. Lateef Unnisa, Prof.M.Sumakanth&Dr.M.N.A.Rao
|
3 | A novel synthesis , Characterization and Docking studies of 2-Thio-Substituted Benzo(d)thiazole derivatives Ms. Paidakula Megha, Prof.M.Sumakanth&Dr.Y.V.D.Nageswar
|
4 | Synthesis characterization and docking studies of 2-substitutd 6-aryl pyridizin -3(2H)-ones as Dopaminengic agents Ms. N Mounika Jagan, Prof.M.Sumakanth
|
5 | Synthesis characterization and docking studies of some novel series of 7-(o-Triazolopyridazin-3yl)-4-methyl coumarins as cox-2 inhibitors, Ms. K Rama, Prof.M.Sumakanth
|
6 | Synthesis ,characterization ,& docking studies of novel series of 2-[5(1H)tetrazolo]-yl-6-aryl-4,5-dihydro/dehydro-pyridazin-3(2H)-on,e Ms. Saritha Pola, Prof.M.Sumakanth
|
7 | Synthesis and docking studies of 3,7-disubstituted Pyridazin[6,1-C][1,2,4)-Triazines as novel PDE-4 inhibitors, Ms. Spoorthi Pohar, Prof.M.Sumakanth
|
8 | Synthesis and molecular modeling of novel 2–substituted -6-Aryl pyridazin-3(2H)ones as 5HT2A Antagonist,s Ms. A Sravya, Prof.M.Sumakanth
|
9 | Synthesis , characterization and biological evaluation of Mannich bases of 7(hydroxyl)-4-methyl coumarin derivatives, Ms. Sukanya Mandala, Prof.M.Sumakanth
|
10 | Synthesis , Characterization and biological evaluation of novel 1,2,3 Tri-substituted Indoles, Ms. K Suneetha, Prof.M.Sumakanth
|
11 | Synthesis , characterization and biological evaluation of a Schiff’s bases of 2-(2-oxo-2-aryl)ethyl Pyridazin-3-thiones. Ms. Nageswari P.V, Prof.M.Sumakanth
|
12 | Synthesis , Docking studies and in vitro evaluation of Novel 4-(benzo[d] thiazol-2-yl)-N-phenylalanine derivatives, Ms. N.S.P.Sirisha, Prof.M.Sumakanth&Dr.Y.V.D.Nageswar
|
13 | Synthesis , characterization and Docking studies of Novel 6-Aryl – 2-(Piperidin-1-yl/Pyrrolidin-1-yl) Benzothiazole derivatives. Ms. Vijaya Laxmi T, Prof.M.Sumakanth&Dr.Rajeev.S.Menon
|
14 | Molecular docking & Virtual screening for Novel protein tyrosine Phosphatane 1B(PTPIB) inhebitors Ms. Rajitha Kalashikam, Dr.Pasupuleti Sreenivasa Rao
|
15 | Homology Modeling & validation of Human FGFR 4 tyrosine kinase domine using structure based studies Ms. Poonam Chakravarthy, Prof.M.Sumakanth
|
16 | In-Silico of Inhibitors for the Human SIAH2, implications for Hypoxia- induced cancers. Sailaja Kota, Dr.Pasupuleti Sreenivasa Rao
|
2014
Department of Pharmaceutical Chemistry
S.No. | Title of the project | ||||
1 | Insilico Screening of Novel substituted purine derivatives as HSP 90 Inhibitors by 3D QSAR and Docking studies .Prof. M Sumakanth , M.Pharm,Ph.DSupervisor
|
||||
2 | Homology modeling of STAT 3 protien and virtual Screening of novel STAT 3 inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor
|
||||
3 | Developing of new derivatives of Indenoisoquinolene as DNA topoisomerese inhibitor by using fragment based drug designing approach.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D(Internal)
|
||||
4 | Pharmacophore Modeling, 3D QSAR, ADMET and Docking studies of Benzisothiazol & Oxadiazole hybrid derivatives as Dengue Virus NS2B/NS3 Protease inhibitors.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D(Internal)
|
||||
5 | Virtual screening of new triazolo derivatives as JAK 2 inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor
|
||||
6 | Homology modeling of TRPV1 protein and Insilico Screening of Novel Inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor
|
||||
7 | Insilico Screening of pyridoimidazolones & substituted pyrazoles as novel inhibitors of B RAF kinase by 3D QSAR, and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor
|
||||
8 | Virtual screening of novel Rho kinase inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.D(External)
|
||||
9 | Insilico Screening of novel 5 LOX inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth, M.Pharm,Ph.DSupervisor
|
||||
10 | Molecular modelling of Indoline derivatives as transforming growth factor beta receptor 1 (TGFBR) inhibitors by 3D QSAR and docking studies.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth, M.Pharm,Ph.D(Internal)
|
2014
Department of Pharmaceutics
.No. | Tittle of the project |
1 | Preparation and physicochemical characterization of vincristine sulphate loaded polycaprolactone nanoparticles by various techniques.Dr. S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. G Uma Rani,M.Pharm(Internal)
|
2 | Formulation and evaluation of extended release tablets of desvenlafaxine succinate.Mr.G Ramesh,PDL & TTD Manager(External)Aurobindo Pharma Ltd.Dr. B L R Madhavi, M.Pharm,Ph.D(Internal)
|
3 | Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by solvent evaporation technique and salting out method.Dr. A Krishna Sailaja, M.Pharm,Ph.DSupervisor
|
4 | Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by nanoprecipitation and ionic gelation methodDr. A Krishna Sailaja, M.Pharm, Ph.DSupervisor
|
5 | Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by solvent evaporation and ionotropic gelation method.Dr. A Krishna Sailaja, M.Pharm,Ph.DSupervisor
|
6 | Development & characterization of xanthum gum and chitosan polyelectrolyte complex as drug delivery carrier.Dr.S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. K V Ratnamala, M.Pharm(Internal)
|
7 | Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by nano precipitation and desolvation technique.Dr.A Krishna Sailaja, M.Pharm,Ph.DSupervisor
|
8 | Formulation & evaluation of or dispersible tablets of candasartan using natural super disintegrants.Mrs. G Uma Rani, M.PharmSupervisor |
9 | Formulation and evalution oof immediate release tablets of quinaprial Hcl by direct compression method.Dr.B L R Madhavi,M.Pharm,Ph.DSupervisor
|
10 | Mr.Sridhar,M.Pharm(External)Pelcoat formulations pvt.ltd. survey no.13, kucharam village,toopran mandal,medak district.502336.Dr. A Krishna Sailaja ,M.Pharm,Ph.D(Internal) Pelcoat formulations pvt.ltd. survey no.13, kucharam village,toopran mandal, medak district. 502336.
|
11 | Formulation and evaluation of non effervescent gastric floating tablets of ceferoxime axitel.Mrs. K V Ratnamala,M.Pharm.Supervisor |
2013
Department of Pharmaceutical Chemistry
S.No. | Tittle of Project |
1 | Synthesis , Charecterization , Docking studies and Biological evalution of 2,4,5,6 tetra substituted Pyridazin-3(2H)-ones
Prof.M.Sumakanth |
2 | Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Sulfamoyl Phenyl Pyridazinones
Prof.M.Sumakanth |
3 | Optimization , Charaterization & impurity profile of Telmisartian by improved synthetic rout and evaluation of Antihypertensive activity of impurity (Chloro analaog)
Prof.M.Sumakanth |
4 | Synthesis , Characterization and Docking studies of Novel series of Pyridazinone substituted Benzene Sulfonyl Ureas
Prof.M.Sumakanth |
5 | Synthesis , Characterization , Docking and Biological Evalution of Novel Pyrimido(4,5-C) Pyridazines
Prof.M.Sumakanth |
6 | Synthesis , Characterization , and In-Sillico evalution of Phthalazine derivatives as Antihypertensive agents
Prof.M.Sumakanth |
7 | Synthesis , Characterization , Docking studies , and Biological evalution of Novel series of 4 Pyrazolyl Substituted Pyridazinones
Prof.M.Sumakanth |
8 | Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Mannich bases of pyridazin 3(2H) thione
Prof.M.Sumakanth |
2013
Department of Pharmaceutics
S.No. | Tittle of Project |
1 | Design , Development and Evaluation of Prednisolone Sodium Phosphate Orodispersible Tablets.
Dr.B.L.R. Madhavi |
2 | Formulation and Evaluation of Sustained Release Matrix Tablets of Niacin
Mrs. Ratnamala K V |
3 | Formulation , Characterization of imquimod w/o/w multiple emulsion for Novel Adjuvant delivery system
Dr. H Sampath Kumar |
4 | Development and Evaluation of Compression coated timed release tablets of Candesartan Cilexetil for Chronotherapy
Dr.B.L.R. Madhavi |
5 | Formulation and Evaluation of Compression coated immediate release tablets of Oseltamivir Phosphate
Dr.B.L.R. Madhavi |
6 | Formulation and Evaluation of Quinapril Hydrochloride for oral sustained release
Dr.B.L.R. Madhavi |
7 | Development of Nasal drug delivery system of Atorvastatin Calcium for enhancing bioavailability
Mrs. G Uma Rani |
8 | Formulation and Evaluation of core coated colon specific tablets of Piroxicam
Dr. A.K.Sailaja |
9 | A study of formulation of micro particle of Cefuroxime Axetil using Ethyl Cellulose
Dr.B.L.R. Madhavi |
10 | Development and Evaluation of Naringenin loaded PLGA Nano particles for enhancement of oral Bioavailability
Mr. S. Ramakrishna |
11 | Formulation and Evaluation of micro emulsions encompasing Muramyl dipeptide adjuvant as Novel Vaccine delivery system
Dr. H.M. Sampath Kumar |
2012
Department of Pharmaceutical Chemistry
S.No. | Tittle of Project |
1 | Synthesis & Docking studies of novel series of Pyridazine(6,1-c)(1,2,4) triazine derivatives as PDE4 inhibitors
Prof.M.Sumakanth |
2 | Development of Industrial process for N-methyl pyridine-2-aldoxamine salts of Pharmaceutical importance.
Prof.M.Sumakanth&Dr.M.N.A.Rao |
3 | A novel synthesis , Characterization and Docking studies of 2-Thio-Substituted Benzo(d)thiazole derivatives
Prof.M.Sumakanth&Dr.Y.V.D.Nageswar |
4 | Synthesis characterization and docking studies of 2-substitutd 6-aryl pyridizin -3(2H)-ones as Dopaminengic agents
Prof.M.Sumakanth |
5 | Synthesis characterization and docking studies of some novel series of 7-(o-Triazolopyridazin-3yl)-4-methyl coumarins as cox-2 inhibitors
Prof.M.Sumakanth |
6 | Synthesis ,characterization ,& docking studies of novel series of 2-[5(1H)tetrazolo]-yl-6-aryl-4,5-dihydro/dehydro-pyridazin-3(2H)-one
Prof.M.Sumakanth |
7 | Synthesis and docking studies of 3,7-disubstituted Pyridazin[6,1-C][1,2,4)-Triazines as novel PDE-4 inhibitors
Prof.M.Sumakanth |
8 | Synthesis and molecular modeling of novel 2–substituted -6-Aryl pyridazin-3(2H)ones as 5HT2A Antagonists
Prof.M.Sumakanth |
9 | Synthesis , characterization and biological evaluation of Mannich bases of 7(hydroxyl)-4-methyl coumarin derivatives
Prof.M.Sumakanth |
10 | Synthesis , Characterization and biological evaluation of novel 1,2,3 Tri-substituted Indoles
Prof.M.Sumakanth |
11 | Synthesis , characterization and biological evaluation of a Schiff’s bases of 2-(2-oxo-2-aryl)ethyl Pyridazin-3-thiones.
Prof.M.Sumakanth |
12 | Synthesis , Docking studies and in vitro evaluation of Novel 4-(benzo[d] thiazol-2-yl)-N-phenylalanine derivatives
Prof.M.Sumakanth&Dr.Y.V.D.Nageswar |
13 | Synthesis , characterization and Docking studies of Novel 6-Aryl – 2-(Piperidin-1-yl/Pyrrolidin-1-yl) Benzothiazole derivatives.
Prof.M.Sumakanth&Dr.Rajeev.S.Menon |
14 | Molecular docking & Virtual screening for Novel protein tyrosine Phosphatane 1B(PTPIB) inhebitors
Dr.Pasupuleti Sreenivasa Rao |
15 | Homology Modeling & validation of Human FGFR 4 tyrosine kinase domine using structure based studies
Prof.M.Sumakanth |
16 | In-Silico of Inhibitors for the Human SIAH2, implications for Hypoxia- induced cancers.
Dr.Pasupuleti Sreenivasa Rao |